IgA Monoclonal Gammopathy with Pseudohyperphosphatemia

[1]  K. Kritmetapak,et al.  Pseudohyperphosphatemia in a patient with relapsed multiple myeloma after bone marrow transplantation: A case report , 2019, Clinical case reports.

[2]  G. Vaidya,et al.  Pseudohyperphosphatemia in multiple myeloma: A commonly misdiagnosed phenomenon , 2014 .

[3]  Sutirtha Chakraborty,et al.  Spurious Hyperphosphatemia in a Case of Multiple Myeloma , 2014, Indian Journal of Clinical Biochemistry.

[4]  M. Brigden,et al.  Factitious biochemical measurements resulting from hematologic conditions. , 2009, American journal of clinical pathology.

[5]  Helen Smith,et al.  Spurious hyperphosphataemia caused by an IgA paraprotein: a topic revisited , 2004, Annals of clinical biochemistry.

[6]  C. Marcu,et al.  Pseudohyperphosphatemia in a patient with multiple myeloma. , 2004, Connecticut medicine.

[7]  H. Drexler,et al.  Malignant hematopoietic cell lines: in vitro models for the study of multiple myeloma and plasma cell leukemia. , 2000, Leukemia research.

[8]  R. Kyle,et al.  Guidelines for clinical and laboratory evaluation patients with monoclonal gammopathies. , 1999, Archives of pathology & laboratory medicine.

[9]  L. Lai,et al.  Pseudohyperphosphataemia in Multiple Myeloma , 1992, Annals of clinical biochemistry.

[10]  B. Goldsmith,et al.  Multiple Myeloma: The Case of the Disappearing Band , 2017, Laboratory medicine.

[11]  Terry M Therneau,et al.  Review of 1027 patients with newly diagnosed multiple myeloma. , 2003, Mayo Clinic proceedings.